- Investing Ideas
- /
- German Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
German Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
1
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
1 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
GXI | €71.00 | 1.4% | -24.7% | €2.5b | €112.92 | PE21.5x | E21.8% | 1.8% |
Page 1 of 1